Follow on Google News News By Tag Industry News * Pharmaceutical * More Industries... News By Location Country(s) Industry News
Follow on Google News | Understand FDA developments & EU regulations for Biosimilars on 24th & 25th September, LondonVariations in global regulatory strategy for biosimilars outside Europe, Japan and the US
By: SMi Group With a focus on industry case studies this conference will be the perfect forum to discuss the rising development cost of biosimilars and successful marketing and pricing strategies. Heinz Haenel, Senior Project Director, Sanofi, will be present an in-depth view into Biosimilar development for recombinant human insulin with a focus on market access in developing countries. Reasons to attend this outstanding conference include: • Examine the latest developments in biosimilar pipelines around the world • Discover the impact of recent guidelines issued by regulatory bodies such as the FDA and EMEA • Develop plans and methods for biosimilar and biobetter drug design and clinical testing • Learn about new variations in global regulatory strategies for biosimilar development • Evaluate current and future developments in intellectual property and patent protection • Hear from industry and academia on the development process from a pre-clinical perspective • Consider market access pathways and learn from past success stories • Understand and make the most of opportunities for long term growth in follow on biologics • Network and learn from key opinion leaders from the field Companies already Registered include: Harvest Moon Pharmaceuticals Teva Pharamceuticals Tiber Creek Partners Amgen Hospira UK Limited Chiesi Farmaceutici S. P. A. Takeda Pharmaceuticals Frontline Pharma Consulting Ltd Merck Research Laboratories Pfizer NTC pharma Sandoz Actavis GlaxoSmithKline Sanofi-Aventis Quintiles Abbott Thomson Reuters Novartis FIOCRUZ With limited amount of spaces ensure you book your place now! Visit www.smi-online.co.uk/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|